High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti‐HER2 therapy

201588 citationsJournal Articlehybrid Open Access

Authors

Quantitative HER2 measurement by SRM-MS is superior to IHC and ISH in predicting outcome after treatment with anti-HER2 therapy.

Good health and well-being

Published in: Molecular Oncology

Volume 10, Issue 1, pp. 138-147

Field-Weighted Citation Impact: 4.46